Table 6.
Supplement | Effect | Mechanism | References |
---|---|---|---|
n-3 PUFA (C20:5 n-3; C22:6 n-3) |
Inflammation (-) Mitigation of pro-inflammatory response (reduced TNF1 and IL-62 production) of immune cells to high NEFA3 concentrations (as those observed with high lipomobilization) Immune competence (±) Improved lymphocytes and mononuclear cells function in transition period: improved cell-mediated immune response; increased phagocytosis and decreased oxidative stress damages in PMN4, leading to improved uterine and udder health in early lactation; modified mononuclear cells/PMN4 ratio |
Decrease the amount of arachidonic acid in cell membranes, shifting the oxylipid profile: increased production of resolvins, protectins and lipoxins/ reduced production of PGF2A8 from endometrium (that exert pro-inflammatory effect) and of prostaglandin E2 (that impairs IFNγ synthesis and lymphocytes proliferation). Decreased expression of adhesion molecules involved in inflammatory interactions between leukocytes and endothelial cells; Decreased liver ketogenesis; Direct action on Toll-like receptor 4 inhibiting the LPS-induced NF-κB activation reduces the expression of transcription factors and PICs5. Activates PPARG reducing the production of TNF by leukocytes and partially reversing the insulin resistance caused by this cytokine, thus increasing the glucose available for leukocytes |
Kushibiki et al., 2001; Lee et al., 2003; Trebble et al., 2003; Lessard et al., 2004; Mattos et al., 2004; Brassard et al., 2007; Ballou et al., 2009b; Trevisi et al., 2011b; Contreras et al., 2012b; Contreras et al., 2012a; Bionaz et al., 2013a; Dirandeh et al., 2013; Minuti et al., 2015a |
n-6 PUFA (C18:2 cis-9 trans-11 and trans-10 cis-12) | Inflammation (-) Increased albumin and cholesterol concentrations in early lactation |
Modulation of the NF-κB9 inhibiting the LPS10-induced inflammatory activity in macrophages | Cheng et al., 2004; Trevisi and Bertoni, 2008; Silvestre et al., 2011 |
Immune competence (±) Enhanced neutrophils function in transition period |
Protection of paraoxonase against oxidative inactivation, reducing oxidative stress status; Increased secretion of VLDL11 and apolipoprotein B100 (involved in lipid redistribution through tissues), decreasing cellular accumulation of triglycerides from palmitic acid, increasing DMI12, reducing NEB13 and lipomobilization (lower NEFA3 and BHB14 levels in blood) |
||
Vitamin A | Prevention of oxidative stress status | β-carotene prevents fatty acid peroxidation chain reaction | Sordillo, 2016 |
Vitamin C | Mitigation of oxidative stress status | Ascorbic acid act as a radical scavenger | Sordillo, 2016 |
Vitamin E | Mitigation of oxidative stress status | α-tocopherol disrupts fatty acid peroxidation chain reaction | Trevisi et al., 2011b; Sordillo, 2016 |
Vitamin D3 | Inflammation (-) Down-regulation of PICs5 in favor of AICs6 production |
Inhibits Th1 sub-family of lymphocytes in favor of Th 2 | Bertoni et al., 2015 |
Selenium | Mitigation and prevention of oxidative stress status | Active component of thioredoxin reductase and glutathione peroxidase enzymatic complexes, that controls redox signaling and reduce ROM15 production | Sordillo, 2016 |
Copper | Mitigation and prevention of oxidative stress status | Active component of ceruloplasmin, that exert oxidase activity as peroxyl radical scavenger, and superoxide dismutase, that converts cytosol superoxide to H2O2 | Osorio et al., 2016; Sordillo, 2016 |
Zinc | Mitigation and prevention of oxidative stress status | Active component of superoxide dismutase, that converts cytosol superoxide to H2O2, and metallothionein, which is a cysteine-rich radical scavenger | Sordillo, 2016 |
Manganese | Mitigation of oxidative stress status | Active component of superoxide dismutase that converts cytosol superoxide to H2O2 | Osorio et al., 2016; Sordillo, 2016 |
Iron | Mitigation of oxidative stress status | Active component of catalase, that converts H2O2 to water | Sordillo, 2016 |
Choline | Reduced hepatic triglycerides abundance and fat infiltrations; mitigation of oxidative stress status | Quasi-vitamin that is a structural component of phosphatidylcholine, that is required for the synthesis of VLDL11 by the liver; important sources of the intracellular antioxidants glutathione and taurine | Esposito et al., 2014; Zhou et al., 2016 |
Methionine and lysine | Reduced hepatic triglycerides abundance and fat infiltrations; mitigation of oxidative stress status | They affect mitochondrial beta-oxidation of fatty acids in liver and export of triglycerides as VLDL11; important sources of the intracellular antioxidants glutathione and taurine | Esposito et al., 2014; Zhou et al., 2016 |
Acetylsalicylic acid | Inflammation (-): Reduced positive APPs7 abundance and improved liver synthesis |
Inhibition of cyclooxygenase enzymatic complex reducing the synthesis of pro-inflammatory oxylipids | Trevisi et al., 2003; Bertoni et al., 2007; Trevisi and Bertoni, 2008; Shin et al., 2010; Kim et al., 2012; Grossi et al., 2013 |
Hottuynia cordata extract | Inflammation (-): Reduced production of TNF1 and pro-inflammatory oxylipids |
Shin et al., 2010; Kim et al., 2012 | |
Aloe arborescens Mill. extract | Inflammation (-): Increased negative APPs7 concentration |
Reduced mobilization of body fats and improved liver synthesis | Trevisi et al., 2013, 2017 |
1Tumor necrosis factor.
2Interleukin-6.
3Non-esterified fatty acids.
4Polymorhonuclear cells.
5Pro-inflammatory cytokines.
6Anti-inflammatory cytokines.
7Acute phase proteins.
8Prostaglandin 2, alpha.
9Nuclear factor κB.
10Lypopolysaccharides.
11Very low-density lipoproteins.
12Dry matter intake.
13Negative energy balance.
14Beta-hydroxybutyrate.
15Reactive oxygen metabolites.